Aurinia Pharmaceuticals Inc AUPH
$15.47
+1.91%
at last close
Analyst Consensus
- Consensus Rating
- Hold (1 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $17.67
- Implied Upside
- +14.2%
- Price Target Range
- $16.00 – $21.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | RBC CapitalDouglas Miehm |
Maintains | Sector perform | $15 → $16 |
| 2025-12-03 | Leerink PartnersJoseph Schwartz |
Downgrades | Outperform → Market perform | $15 → $16 |
| 2025-11-07 | JefferiesMaury Raycroft |
Upgrades | Hold → Buy | $10 → $21 |
| 2025-11-05 | RBC CapitalDouglas Miehm |
Downgrades | Outperform → Sector perform | $9 → $15 |
| 2025-08-01 | RBC CapitalDouglas Miehm |
Maintains | Outperform | $8 → $9 |
| 2025-07-30 | HC Wainwright & Co.Arthur He |
Assumes | Buy | $17 |
| 2024-09-16 | Cantor FitzgeraldOlivia Brayer |
Reiterates | Overweight | $10 |
| 2024-09-09 | Cantor FitzgeraldOlivia Brayer |
Reiterates | Overweight | $10 |
| 2024-09-06 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $13 |
| 2024-03-01 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $13 |
| 2024-02-23 | Cantor FitzgeraldOlivia Brayer |
Maintains | Overweight | $12 → $10 |
| 2024-02-22 | HC Wainwright & Co.Ed Arce |
Maintains | Buy | $15 → $13 |
| 2024-02-16 | RBC CapitalDouglas Miehm |
Maintains | Outperform | $13 → $8 |
| 2023-09-22 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $15 |
| 2023-08-07 | HC Wainwright & Co.Ed Arce |
Maintains | Buy | $14 → $15 |
| 2023-07-06 | Cantor FitzgeraldOlivia Brayer |
Reiterates | Overweight | $15 |
| 2023-05-03 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $14 |
| 2023-02-23 | RBC CapitalDouglas Miehm |
Reiterates | Outperform | $11 |
| 2023-01-04 | RBC CapitalDouglas Miehm |
Maintains | Outperform | $10 → $11 |
| 2022-11-07 | HC Wainwright & Co.Ed Arce |
Maintains | Buy | $26 → $14 |
| 2022-11-04 | RBC CapitalDouglas Miehm |
Maintains | Outperform | $18 → $10 |
| 2022-11-04 | OppenheimerJustin Kim |
Downgrades | Outperform → Perform | — |
| 2022-11-04 | SVB LeerinkJoseph Schwartz |
Maintains | Outperform | $17 → $12 |
| 2022-08-09 | HC Wainwright & Co.Ed Arce |
Maintains | Buy | $30 → $26 |
| 2022-08-08 | OppenheimerJustin Kim |
Maintains | Outperform | $15 → $13 |
| 2022-05-05 | Cantor FitzgeraldOlivia Brayer |
Assumes | Overweight | $25 |
| 2022-05-05 | HC Wainwright & Co.Ed Arce |
Maintains | Buy | $33 → $30 |
| 2022-04-28 | RBC CapitalDouglas Miehm |
Maintains | Outperform | $27 → $22 |
| 2022-03-08 | SVB LeerinkJoseph Schwartz |
Maintains | Outperform | $30 → $22 |
| 2022-03-01 | RBC CapitalDouglas Miehm |
Maintains | Outperform | $31 → $27 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $15.47
- Market Cap
- $2.06 billion
- 52-Week Range
- $8.28 – $19.25
- Average Volume
- 1.23 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.